The Patent Finder
DR

DR. Reddy's Laboratories Limited

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

7 patents currently held

28 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2036. from the record

Of the 28 now held by other companies, 10 name Primus Pharmaceuticals Inc. as their current owner, and 18 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2036
Next term end
7
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 13 later US patents, top 25% of utility patents granted in 2017 in our data. Protection runs to 2030. A terminal disclaimer caps this term to an earlier patent's.
Ends Jun 2030 · Low confidence
Also notable
The largest patent family in this portfolio, 11 related applications, renewed at every maintenance window due so far. Protection runs to 2030.
Ends Aug 2030 · High confidence
Also notable
The largest patent family in this portfolio, 7 related applications, renewed at every maintenance window due so far. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Ends May 2036 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Stable Fusion Protein Formulation1 in forceto Apr 2042
Antibody Formulation1 in forceto Oct 2041
Stable Formulations of Therapeutic Antibody1 in forceto Jul 2040
Stable Antibody Formulation1 in forceto Jan 2040
Solid State Forms of Lenvatinib Mesylate1 in forceto Aug 2038

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

PatentTitleStatusExpiresConfidence
US 12,673,040Pharmaceutical Composition for Treating Migraine
In force
 · Low confidence
In forceLow confidence
US 11,639,391Stable Liquid Pharmaceutical Composition
In force
 · High confidence
In forceHigh confidence
US 11,084,791Solid State Forms of Lenvatinib Mesylate
In force
 · High confidence
In forceHigh confidence
US 12,024,561Stable Antibody Formulation
In force
 · High confidence
In forceHigh confidence
US 12,433,947Stable Formulations of Therapeutic Antibody
In force
 · High confidence
In forceHigh confidence
US 12,030,948Antibody Formulation
In force
 · High confidence
In forceHigh confidence
US 12,428,464Stable Fusion Protein Formulation
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 28 patents in force now held by others · 87 patents ended · 22 applications pending · 221 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited